ProstaScint (Cytogen Corp)
ProstaScint (Cytogen Corp) Brand names, ProstaScint (Cytogen Corp) Analogs
ProstaScint (Cytogen Corp) Brand Names Mixture
- No information avaliable
ProstaScint (Cytogen Corp) Chemical_Formula
No information avaliable
ProstaScint (Cytogen Corp) RX_link
No information avaliable
ProstaScint (Cytogen Corp) fda sheet
ProstaScint (Cytogen Corp) msds (material safety sheet)
ProstaScint (Cytogen Corp) Synthesis Reference
No information avaliable
ProstaScint (Cytogen Corp) Molecular Weight
No information avaliable
ProstaScint (Cytogen Corp) Melting Point
61 oC (FAB fragment), 71 oC (whole mAb)-Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).
ProstaScint (Cytogen Corp) H2O Solubility
No information avaliable
ProstaScint (Cytogen Corp) State
Liquid
ProstaScint (Cytogen Corp) LogP
No information avaliable
ProstaScint (Cytogen Corp) Dosage Forms
Solution (IV Infusion)
ProstaScint (Cytogen Corp) Indication
For diagnosis of prostate cancer and detection of intra-pelvic metastases
ProstaScint (Cytogen Corp) Pharmacology
Binds to the prostate-specific membrane antigen, which is a cell surface protein generally overexpressed in prostate tissues and prostate cancers. The radioactive Indium 111, which is covalently attached to the antibody, allows radiodiagnostic detection of PSMA expressing cells and tumors
ProstaScint (Cytogen Corp) Absorption
No information avaliable
ProstaScint (Cytogen Corp) side effects and Toxicity
No information avaliable
ProstaScint (Cytogen Corp) Patient Information
No information avaliable
ProstaScint (Cytogen Corp) Organisms Affected
Humans and other mammals
